Can GLP-1 medications reduce acne and hirsutism in PCOS?
GLP-1 receptor agonists may offer metabolic and hormonal benefits in women with PCOS. Studies show they support weight loss and can modestly reduce total testosterone, which may help some androgen-related symptoms. Evidence for improvement in hirsutism is mixed, and evidence for acne improvement is limited because it is not routinely measured in trials.
Key points:
- GLP-1 receptor agonists support weight loss and improve metabolic parameters in PCOS.
- Clinical studies show modest reductions in total testosterone levels.
- Some studies report small improvements in hirsutism scores, though findings vary.
- Evidence for acne improvement is limited and not consistently measured.
- Benefits are largely linked to weight loss and metabolic changes; direct hormonal effects remain under study.
This text has been fact-checked for accuracy by Sorin Romaniuc, Pharmacist at medino.